Literature DB >> 2014886

The AIDS epidemic in New York State.

P F Smith, J Mikl, S Hyde, D L Morse.   

Abstract

New York State has reported more AIDS cases (26,576) through November 1989 than any other state, accounting for 23 percent of all reported cases in the nation at the time. New York City has reported 22,231 (84 percent) of the statewide cases. The epidemiology of AIDS in New York State has been easily influenced by the large number of cases among IVDUs. Whereas intravenous drug use accounts for 16 percent of adult/adolescent cases in the rest of the nation, it accounts for 39 percent of the cases in New York State. Intravenous drug use is the leading exposure category among racial minorities, with a disproportionately high rate of cases among Blacks and Hispanics. The epidemic among women and children has also been severe, resulting from intravenous drug use by women, heterosexual transmission from drug users to women, and perinatal transmission to their children.

Entities:  

Mesh:

Year:  1991        PMID: 2014886      PMCID: PMC1404756          DOI: 10.2105/ajph.81.suppl.54

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  5 in total

1.  Newborn seroprevalence study: methods and results.

Authors:  L F Novick; D M Glebatis; R L Stricof; P A MacCubbin; L Lessner; D S Berns
Journal:  Am J Public Health       Date:  1991-05       Impact factor: 9.308

2.  Acquired immunodeficiency syndrome (AIDS)-free time after human immunodeficiency virus type 1 (HIV-1) seroconversion in homosexual men. Multicenter AIDS Cohort Study Group.

Authors:  A Muñoz; M C Wang; S Bass; J M Taylor; L A Kingsley; J S Chmiel; B F Polk
Journal:  Am J Epidemiol       Date:  1989-09       Impact factor: 4.897

3.  Incubation period of AIDS in San Francisco.

Authors:  P Bacchetti; A R Moss
Journal:  Nature       Date:  1989-03-16       Impact factor: 49.962

4.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

5.  Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.

Authors:  R C Gallo; S Z Salahuddin; M Popovic; G M Shearer; M Kaplan; B F Haynes; T J Palker; R Redfield; J Oleske; B Safai
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

  5 in total
  3 in total

1.  Expanded syringe access demonstration program in New York State: an intervention to prevent HIV/AIDS transmission.

Authors:  S J Klein; G S Birkhead; A R Candelas
Journal:  J Urban Health       Date:  2000-12       Impact factor: 3.671

2.  What do pharmacists think about New York state's new nonprescription syringe sale program? Results of a survey.

Authors:  S J Klein; K Harris-Valente; A R Candelas; M Radigan; M Narcisse-Pean; J M Tesoriero; G S Birkhead
Journal:  J Urban Health       Date:  2001-12       Impact factor: 3.671

3.  Injection drug use, mortality, and the AIDS epidemic.

Authors:  P A Selwyn
Journal:  Am J Public Health       Date:  1991-10       Impact factor: 9.308

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.